Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Patient outcomes remain poor for many cancers despite improvements in treatments and new molecular-targeted biomedicines for certain cancer types or subtypes. Dose-limiting toxicity, a narrow therapeutic index, and the development of resistance to traditional anti-cancer agents are well-established....
Guardado en:
Otros Autores: | |
---|---|
Formato: | Electrónico Capítulo de libro |
Lenguaje: | inglés |
Publicado: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Materias: | |
Acceso en línea: | DOAB: download the publication DOAB: description of the publication |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Internet
DOAB: download the publicationDOAB: description of the publication
3rd Floor Main Library
Número de Clasificación: |
A1234.567 |
---|---|
Copia 1 | Disponible |